Avecho Biotechnology Limited logo

AVEAvecho Biotechnology Limited

AVE Stock Price, Valuation & Chart | Avecho Biotechnology Limited

Compare

AVE Historical price chart

AVE Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization85.00M
PE Ratio-15.49
EPS0.0
Trading Volume2.92M
Today's High/Low0.02/0.02
Dividend Yield0.00
52 Week High/Low0.03/0.01
Shares Outstanding3.86B
AVE Financial Statement

AVE Analyst ratings

Buy

Strong buy
0
Buy
0
Hold
0
Sell
0
Strong sell
0

Based on 0 analysts giving stock ratings to AVE in the past 3 months.

AVE Analysis & performance metrics

AVE Company profile

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug…

AVE Management team

Management
Melanie Jaye Leydin B.Bus, C.A.CFO
Company Secretary & Chief Financial Officer
Paul Gavin BSc (Hons), Ph.D.CEO
Chief Executive Officer
Roksan Libinaki Ph.D.COO
Chief Operating Officer
Total 3 executives

AVE Frequently asked questions

What is Avecho Biotechnology Limited (AVE) Stock Price?

Current stock price of Avecho Biotechnology Limited (AVE) stock is $0.020. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Avecho Biotechnology Limited (AVE) stock is 2.92M.

Last updated at 02 Sept 2026, 06:10 am.

Why is the Avecho Biotechnology Limited (AVE) stock price going up or down today?

The stock price of Avecho Biotechnology Limited (AVE) can change with earnings, company news, and overall market sentiment. Avecho Biotechnology Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Avecho Biotechnology Limited stock expensive at its current price?

Whether Avecho Biotechnology Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AVE on this page is -15.49. EPS on this page is 0.00. Compare those figures with peers and growth expectations before deciding if the current Avecho Biotechnology Limited price is justified.

How has the stock price of Avecho Biotechnology Limited (AVE) performed historically?

Historical performance for Avecho Biotechnology Limited (AVE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AVE reacted to past earnings and market events.

Should I buy Avecho Biotechnology Limited (AVE) stock, at this price?

Buying Avecho Biotechnology Limited (AVE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.